Leadership / New CEO Takes Reins at Buoyant CSL
CSL, Australia’s largest biopharma company, overcame the challenges of the pandemic-related decline in plasma collection and has since racked up wins such as the acquisition of Vifor, the largest in…
Australia
Global / Will We Try to Forget the Pandemic in 2023? Five Key Trends
Brendan Shaw looks ahead to the rest of 2023, identifying five key trends to watch out for in the healthcare and life sciences sector. With the worst of COVID-19 now in the rear-view mirror for much of the world, Shaw…
Australia / Pharmaceuticals Take Centre Stage in Election Campaign
Pharmaceutical policy issues played a major role in Australia’s recent national election. Shawview Consulting’s Brendan Shaw outlines the medicines issues that came under scrutiny during the campaign. It was the…
Australia/ Australia Pharma News: Unification of CSL's Business Units, New USD 173 Million Research Centre, Acquisition of CDMO Luina Bio ...
A roundup of some of the latest news from Australian pharma, including CSL’s unification of business units, a workers strike at Pfizer’s manufacturing plant, a new USD 173 million research…